Cargando…
Safety monitoring of COVID-19 vaccines in Japan
The assessment of the efficacy and safety of coronavirus disease 2019 (COVID-19) vaccines in actual practice is extremely important, and monitoring efforts are being implemented worldwide. In Japan, a joint council in the Ministry of Health, Labour and Welfare is held every two to three weeks to sum...
Autores principales: | Yamaguchi, Toshihiro, Iwagami, Masao, Ishiguro, Chieko, Fujii, Daisuke, Yamamoto, Norihisa, Narisawa, Manabu, Tsuboi, Takashi, Umeda, Hikari, Kinoshita, Natsumi, Iguchi, Toyotaka, Noda, Tatsuya, Tsuruta, Shinya, Oka, Akira, Morio, Tomohiro, Nakai, Kiyohito, Hayashi, Shuichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960038/ https://www.ncbi.nlm.nih.gov/pubmed/35359913 http://dx.doi.org/10.1016/j.lanwpc.2022.100442 |
Ejemplares similares
-
Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots and paediatric vaccinations
por: Yamaguchi, Toshihiro, et al.
Publicado: (2022) -
Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for infants and young children
por: Yamaguchi, Toshihiro, et al.
Publicado: (2023) -
Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report
por: Iguchi, Toyotaka, et al.
Publicado: (2021) -
Nested Case‐Control Study Utilizing MID‐NET® on Thrombocytopenia Associated With Pegfilgrastim in Patients Treated With Antineoplastic Agents
por: Kajiyama, Kazuhiro, et al.
Publicado: (2021) -
Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events
por: Kobayashi, Hidetaka, et al.
Publicado: (2022)